- McCormick, Frank
- Shoji, K
- Oda, K
- Kashiyama, T
- Ikeda, Y
- Nakagawa, S
- Sone, K
- Miyamoto, Y
- Hiraike, H
- Tanikawa, M
- Miyasaka, A
- et al.
The PI3K (phosphatidylinositol-3-kinase)/mTOR (mammalian target of rapamycin) pathway is frequently activated in endometrial cancer through various PI3K/AKT-activating genetic alterations. We examined the antitumor effect of NVP-BEZ235-a dual PI3K/mTOR inh